Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome

European Journal of Endocrinology

Volumn 165, Issue 2, 2011, Pages 345-352

  Lima, Kari ^a,b   Abrahamsen, Tore G ^b,c   Wolff, Anette Bøe ^d   Husebye, Eystein ^d,e   Alimohammadi, Mohammad ^f   Kämpe, Olle ^f   Følling, Ivar ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA HYDROXYLASE ANTIBODY; 21 HYDROXYLASE ANTIBODY; AUTOANTIBODY; CALCIUM; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; INTRINSIC FACTOR ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PARATHYROID HORMONE; PARIETAL CELL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; PROTEIN TYROSINE PHOSPHATASE ANTIBODY; SMOOTH MUSCLE ANTIBODY; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; TYROSINE HYDROXYLASE ANTIBODY; UNCLASSIFIED DRUG; VITAMIN D;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CALCIUM BLOOD LEVEL; CHILD; CHROMOSOME DELETION 22Q11; FEMALE; FOLLOW UP; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN HYPOCALCEMIA; NORWAY; PARATHYROID HORMONE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SMALL FOR DATE INFANT; CHROMOSOME 22; GENETICS; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; ANTIBODY DETECTION; BLOOD ANALYSIS; CONTROLLED STUDY; HEALTH SURVEY; HLA TYPING; MEDICAL RECORD; PARATHYROID GLAND; PHYSICAL EXAMINATION; SEMI STRUCTURED INTERVIEW;

22Q11 DELETION SYNDROME; ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 22; FEMALE; HUMANS; HYPOCALCEMIA; HYPOPARATHYROIDISM; INFANT; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 79960168360     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1206     Document Type: Article

References (43)

1. DiGeorge AM. Discussion on a new concept of the cellular basis of immunity. Journal of Pediatrics 1965 67 907-908. (doi:10.1016/S0022-3476(65) 81796-6)
2. Scambler PJ, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R, Wilson DI, Goodship JA, Cross IE & Burn J. Velocardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet 1992 339 1138-1139. (doi:10.1016/0140-6736(92)90734-K)
3. Botto LD, May K, Fernhoff PM, Correa A, Coleman K, Rasmussen SA, Merritt RK, O'Leary LA, Wong LY, Elixson EM, Mahle WT & Campbell RM. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 2003 112 101-107. (doi:10.1542/peds.112.1.101)
4. Adachi M, Tachibana K, Masuno M, Makita Y, Maesaka H, Okada T, Hizukuri K, Imaizumi K, Kuroki Y, Kurahashi H & Suwa S. Clinical characteristics of children with hypoparathyroidism due to 22q11.2 microdeletion. European Journal of Pediatrics 1998 157 34-38. (doi:10.1007/s004310050762)
5. Cuneo BF, Langman CB, Ilbawi MN, Ramakrishnan V, Cutilletta A & Driscoll DA. Latent hypoparathyroidism in children with conotruncal cardiac defects. Circulation 1996 93 1702-1708. (Pubitemid 26131347)
6. Maalouf NM, Sakhaee K & Odvina CV. A case of chromosome 22q11 deletion syndrome diagnosed in a 32-year-old man with hypoparathyroidism. Journal of Clinical Endocrinology and Metabolism 2004 89 4817-4820. (doi:10.1210/jc.2004-0442)
7. Kapadia CR, Kim YE, Donald-McGinn DM, Zackai EH & Katz LE. Parathyroid hormone reserve in 22q11.2 deletion syndrome. Genetics in Medicine 2008 10 224-228. (doi:10.1097/GIM.0b013e3181634edf)
8. Jawad AF, Donald-McGinn DM, Zackai E & Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/ velocardiofacial syndrome). Journal of Pediatrics 2001 139 715-723. (doi:10.1067/mpd.2001.118534)
9. Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M & Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Archives of Disease in Childhood 2002 86 422-425. (doi:10.1136/adc.86.6.422)
10. Kratz CP, Niehues T, Lyding S, Heusch A, Janssen G & Gobel U. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatric Hematology and Oncology 2003 20 167-172. (doi:10.1080/ 0880010390158685)
11. DePiero AD, Lourie EM, Berman BW, Robin NH, Zinn AB & Hostoffer RW. Recurrent immune cytopenias in two patients with DiGeorge/velocardiofacial syndrome. Journal of Pediatrics 1997 131 484-486. (doi:10.1016/S0022-3476(97) 80085-6)
12. Sullivan KE, Jawad AF, Randall P, Driscoll DA, Emanuel BS, McDonald-Mcginn DM & Zackai EH. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clinical and Experimental Immunology 1998 86 141-146. (doi:10.1006/clin.1997.4463)
13. Digilio MC, Giannotti A, Castro M, Colistro F, Ferretti F, Marino B & Dallapiccola B. Screening for celiac disease in patients with deletion 22q11.2 (DiGeorge/velo-cardio-facial syndrome). American Journal of Medical Genetics. Part A 2003 121A 286-288. (doi:10.1002/ajmg.a.20254)
14. Piliero LM, Sanford AN, Donald-McGinn DM, Zackai EH & Sullivan KE. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 2004 103 1020-1025. (doi:10.1182/blood-2003-08-2824)
15. Lima K, Abrahamsen TG, Foelling I, Natvig S, Ryder LP & Olaussen RW. Low thymic output in the 22q11.2 deletion syndrome measured by CCR9CD45RA T cell counts and T cell receptor rearrangement excisioncircles. Clinical and Experimental Immunology 2010 161 98-107. (doi:10.1111/j.1365-2249.2010.04152.x)
16. Sullivan KE, Donald-McGinn D & Zackai EH. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clinical and Diagnostic Laboratory Immunology 2002 9 1129-1131. (doi:10.1128/CDLI.9.5. 1129-1131.2002)
17. Finocchi A, Di CS, Romiti ML, Capponi C, Rossi P, Carsetti R & Cancrini C. Humoral immune responses and CD27+B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatric Allergy and Immunology 2006 17 382-388. (doi:10.1111/j.1399-3038.2006.00409.x)
18. Smith CA, Driscoll DA, Emanuel BS, Donald-McGinn DM, Zackai EH & Sullivan KE. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/ velocardiofacial syndrome). Clinical and Diagnostic Laboratory Immunology 1998 5 415-417. (Pubitemid 28246471)
19. Davies K, Stiehm ER, Woo P & Murray KJ. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. Journal of Rheumatology 2001 28 2326-2334. (Pubitemid 32947884)
20. Kung SJ, Gripp KW, Stephan MJ, Fairchok MP & McGeady SJ. Selective IgM deficiency and 22q11.2 deletion syndrome. Annals of Allergy, Asthma & Immunology 2007 99 87-92. (doi:10.1016/S1081-1206(10)60627-8)
21. Gavalas NG, Kemp EH, Krohn KJ, Brown EM, Watson PF & Weetman AP. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism 2007 92 2107-2114. (doi:10.1210/jc.2006-2466)
22. Kemp EH, Gavalas NG, Krohn KJ, Brown EM, Watson PF & Weetman AP. Activating autoantibodies against the calciumsensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1. Journal of Clinical Endocrinology and Metabolism 2009 94 4749-4756. (doi:10.1210/jc.2009-1080)
23. Alimohammadi M, BjörklundP, Hallgren A, PöntynenN, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Åkerstrom G, Westin G, Scott HS, Holländer GA & Kämpe O. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. New England Journal of Medicine 2008 358 1018-1028. (doi:10.1056/NEJMoa0706487)
24. Lima K, Folling I, Eiklid KL, Natvig S & Abrahamsen TG. Agedependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndrome. European Journal of Pediatrics 2010 169 983-989. (doi:10.1007/s00431-010-1161-3)
25. Ahonen P, Myllarniemi S, Sipila I & Perheentupa J. Clinical variation of autoimmune polyendocrinopathy - candidiasis - ectodermal dystrophy (APECED) in a series of 68 patients. New England Journal of Medicine 1990 322 1829-1836. (doi:10.1056/NEJM199006283222601)
26. Stray-Pedersen A, Jonsson T, Heiberg A, Lindman CR, Widing E, Aaberge IS, Borresen-Dale AL & Abrahamsen TG. The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxiatelangiectasia patients and their parents. Clinical and Experimental Immunology 2004 137 179-186. (doi:10.1111/j.1365-2249.2004.02492.x)
27. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A & Moonsamy P. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008 57 1084-1092. (doi:10.2337/db07-1331)
28. Söderbergh A, Myhre AG, Ekwall O, Gebre-Medhin G, Hedstrand H, Landgren E, Mietinen A, Eskelin P, Halonen M, Tuomi T, Gustafsson J, Husebye ES, Perheentupa H, Gylling M, Manns MP, Rorsman F, Kämpe O & Nilsson T. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. Journal of Clinical Endocrinology and Metabolism 2004 89 557-562. (doi:10.1210/jc.2003-030279)
29. Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S & Husebye ES. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. Clinical Immunology 2008 129 163-169. (doi:10.1016/j.clim.2008.07.002)
30. Skjaerven R, Gjessing HK & Bakketeig LS. Birthweight by gestational age in Norway. Acta Obstetrica et Gynecologica Scandinavica 2000 79 440-449. (doi:10.1080/j.1600-0412.2000.079006440.x)
31. Choi JH, Shin YL, Kim GH, Seo EJ, Kim Y, Park IS & Yoo HW. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Hormone Research 2005 63 294-299. (doi:10.1159/000086745)
32. Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR & Ochs HD. Primary immune deficiency disorders presenting as autoimmune diseases: IPEX and APECED. Journal of Clinical Immunology 2008 28 S11-S19. (doi:10.1007/s10875-008- 9176-5)
33. Jacob CM, Pastorino AC, Fahl K, Carneiro-Sampaio M & Monteiro RC. Autoimmunity in IgA deficiency: revisiting the role of IgA as a silent housekeeper. Journal of Clinical Immunology 2008 28 S56-S61. (doi:10.1007/s10875-007-9163-2)
34. Prelog M, Keller M, Geiger R, Brandstatter A, Wurzner R, Schweigmann U, Zlamy M, Zimmerhackl LB & Grubeck-Loebenstein B. Thymectomy in early childhood: significant alterations of the CD4(+)CD45RA(+)CD62L(+) T cell compartment in later life. Clinical Immunology 2009 130 123-132. (doi:10.1016/j.clim.2008.08.023)
35. Marin GG, Cardiel MH, Cornejo H & Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. Journal of Clinical Rheumatology 2009 15 325-329. (doi:10.1097/RHU.0b013e3181bb971b)
36. Deane PM, Liard G, Siegel DM & Baum J. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 1995 95 892-895.
37. Husebye ES, Perheentupa J, Rautemaa R & Kämpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I. Journal of Internal Medicine 2009 265 514-529. (doi:10.1111/j.1365- 2796.2009.02090.x)
38. Erichsen MM, Løvas K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H & Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. Journal of Clinical Endocrinology and Metabolism 2009 94 4882-4890. (doi:10.1210/jc. 2009-1368)
39. Coco G, Dal PC, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F & Betterle C. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. Journal of Clinical Endocrinology and Metabolism 2006 91 1637-1645. (doi:10.1210/jc.2005-0860)
40. Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD & Gatzoulis MA. Clinical features of 78 adults with 22q11 deletion syndrome. American Journal of Medical Genetics. Part A 2005 138 307-313. (doi:10.1002/ajmg.a.30984)
41. Bjoro T, Holmen J, Kruger O, Midthjell K, Hunstad K, Schreiner T, Sandnes L & Brochmann H. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trondelag (HUNT). European Journal of Endocrinology 2000 143 639-647. (doi:10.1530/eje.0.1430639)
42. Sullivan KE, Donald-McGinn DM, Driscoll DA, Zmijewski CM, Ellabban AS, Reed L, Emanuel BS, Zackai EH, Athreya BH & Keenan G. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad/velocardiofacial syndrome/conotruncal anomaly face syndrome). Arthritis and Rheumatism 1997 40 430-436. (doi:10.1002/art.1780400307)
43. Herwadkar A, Gennery AR, Moran AS, Haeney MR & Arkwright PD. Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome. Journal of Clinical Pathology 2010 63 151-155. (doi:10.1136/jcp.2009.072074)